KEATING LAURIE
Insider CIK 1620743 · ALNY SVP, GC and Secretary · IMGO Director · KLRS Director · IMRX Director · PEPG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2026-08-01 | 2026-08-03 | 18,000 | — | $0 | 18,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2026-08-01 | 2026-08-03 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2026-06-11 | 2026-06-11 | 33,350 | — | $0 | 33,350 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2026-01-01 | 2026-01-02 | 7,888 | — | $0 | 7,888 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2025-06-13 | 2025-06-16 | 33,350 | — | $0 | 33,350 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2025-01-01 | 2025-01-02 | 23,485 | — | $0 | 23,485 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2024-06-12 | 2024-06-13 | 33,350 | — | $0 | 33,350 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2024-01-01 | 2024-01-02 | 6,879 | — | $0 | 6,879 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2023-06-14 | 2023-06-15 | 17,500 | — | $0 | 17,500 | SEC↗ |
| IMGO Imago BioSciences, Inc. | D To issuer deriv | 2023-01-11 | 2023-01-11 | 23,809 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | D To issuer deriv | 2023-01-11 | 2023-01-11 | 11,904 | — | $0 | 0 | SEC↗ |
| IMRX Immuneering Corp | A Award deriv | 2022-06-21 | 2022-06-23 | 14,200 | — | $0 | 14,200 | SEC↗ |
| IMGO Imago BioSciences, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 11,904 | — | $0 | 11,904 | SEC↗ |
| IMRX Immuneering Corp | P Buy | 2022-05-16 | 2022-05-17 | 7,000 | $5.00 | $35.0K | 14,000 | SEC↗ |
| PEPG PepGen Inc. | P Buy | 2022-05-06 | 2023-01-19 | 4,166 | $12.00 | $50.0K | 4,166 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2022-05-06 | 2022-05-10 | 5,833 | — | $0 | 5,833 | SEC↗ |
| IMGO Imago BioSciences, Inc. | A Award deriv | 2021-11-17 | 2021-11-19 | 23,809 | — | $0 | 23,809 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-08-05 | 2021-08-09 | 7,876 | — | $0 | 1,124 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-08-05 | 2021-08-09 | 2,124 | — | $0 | 11,876 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-08-05 | 2021-08-09 | 10,000 | $188.95 | $1.89M | 5,132 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-08-05 | 2021-08-09 | 2,124 | $88.95 | $188.9K | 15,132 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-08-05 | 2021-08-09 | 7,876 | $88.95 | $700.6K | 13,008 | SEC↗ |
| IMRX Immuneering Corp | P Buy | 2021-08-03 | 2021-08-04 | 7,000 | $15.00 | $105.0K | 7,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-07-12 | 2021-07-14 | 1,812 | — | $0 | 17,188 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-07-12 | 2021-07-14 | 5,000 | — | $0 | 9,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-07-12 | 2021-07-14 | 5,000 | $88.95 | $444.8K | 11,944 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-07-12 | 2021-07-14 | 1,812 | $179.00 | $324.3K | 10,132 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-07-12 | 2021-07-14 | 5,000 | $178.95 | $894.8K | 5,132 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-07-12 | 2021-07-14 | 1,812 | $85.00 | $154.0K | 6,944 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-06-09 | 2021-06-11 | 1,734 | $154.00 | $267.0K | 5,132 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 75 | $134.42 | $10.1K | 6,866 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 2,014 | $131.75 | $265.3K | 6,941 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-04-19 | 2021-04-21 | 4,518 | — | $0 | 8,955 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-24 | 2021-02-26 | 17,846 | — | $0 | 17,846 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-02-12 | 2021-02-16 | 1,857 | $156.00 | $289.7K | 4,543 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-02-12 | 2021-02-16 | 106 | $153.54 | $16.3K | 4,437 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 4,584 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-02-11 | 2021-02-16 | 4,166 | — | $0 | 6,400 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-01-13 | 2021-01-15 | 6,000 | — | $0 | 19,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-01-13 | 2021-01-15 | 3,027 | — | $0 | 2,164 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-01-13 | 2021-01-15 | 3,000 | $170.00 | $510.0K | 3,261 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-01-13 | 2021-01-15 | 5,000 | $169.00 | $845.0K | 6,261 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-01-13 | 2021-01-15 | 1,027 | $174.00 | $178.7K | 2,234 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-01-13 | 2021-01-15 | 3,027 | $77.40 | $234.3K | 5,261 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-01-13 | 2021-01-15 | 6,000 | $85.00 | $510.0K | 11,261 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-01-12 | 2021-01-13 | 1,941 | — | $0 | 2,370 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-01-12 | 2021-01-13 | 13,000 | — | $0 | 5,191 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-01-12 | 2021-01-13 | 1,941 | $42.22 | $81.9K | 4,175 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-01-12 | 2021-01-13 | 3,000 | $165.00 | $495.0K | 2,234 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-01-12 | 2021-01-13 | 13,000 | $77.40 | $1.01M | 17,175 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-01-12 | 2021-01-13 | 11,941 | $159.00 | $1.90M | 5,234 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-01-11 | 2021-01-13 | 758 | $154.00 | $116.7K | 2,234 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-07-13 | 2020-07-14 | 1,941 | — | $0 | 4,311 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-07-13 | 2020-07-14 | 6,250 | — | $0 | 7,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-07-13 | 2020-07-14 | 23,809 | — | $0 | 18,191 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-07-13 | 2020-07-14 | 3,750 | — | $0 | 5,416 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-13 | 2020-07-14 | 1,061 | $159.22 | $168.9K | 42,376 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-13 | 2020-07-14 | 2,323 | $158.27 | $367.7K | 43,437 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-13 | 2020-07-14 | 4,482 | $157.16 | $704.4K | 45,760 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-13 | 2020-07-14 | 9,530 | $162.24 | $1.55M | 2,992 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-07-13 | 2020-07-14 | 3,750 | $119.13 | $446.7K | 43,992 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-07-13 | 2020-07-14 | 23,809 | $77.40 | $1.84M | 40,242 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-07-13 | 2020-07-14 | 1,941 | $42.22 | $81.9K | 16,433 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-13 | 2020-07-14 | 14,236 | $160.52 | $2.29M | 28,140 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-07-13 | 2020-07-14 | 15,618 | $161.32 | $2.52M | 12,522 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-07-13 | 2020-07-14 | 6,250 | $119.13 | $744.6K | 50,242 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-04-20 | 2020-04-22 | 10,000 | — | $0 | 42,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-04-20 | 2020-04-22 | 10,000 | $139.00 | $1.39M | 14,492 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-04-20 | 2020-04-22 | 10,000 | $77.40 | $774.0K | 24,492 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2020-04-07 | 2020-04-09 | 4,167 | — | $0 | 16,425 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 1,858 | $104.75 | $194.6K | 14,567 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 75 | $105.63 | $7.9K | 14,492 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-02-26 | 2020-02-28 | 24,554 | — | $0 | 24,554 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-02-10 | 2020-02-12 | 10,000 | — | $0 | 52,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-10 | 2020-02-12 | 10,000 | $129.00 | $1.29M | 12,258 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-02-10 | 2020-02-12 | 10,000 | $77.40 | $774.0K | 22,258 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-01-29 | 2020-01-31 | 6,337 | — | $0 | 62,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-01-29 | 2020-01-31 | 6,337 | $119.00 | $754.1K | 8,595 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-01-29 | 2020-01-31 | 6,337 | $77.40 | $490.5K | 14,932 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-01-27 | 2020-01-29 | 9,374 | — | $0 | 6,252 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-01-27 | 2020-01-29 | 3,663 | — | $0 | 68,337 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-01-27 | 2020-01-29 | 25,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-01-27 | 2020-01-29 | 13,631 | $116.43 | $1.59M | 32,636 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-01-27 | 2020-01-29 | 6,667 | $119.53 | $796.9K | 8,785 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-01-27 | 2020-01-29 | 13,084 | $118.61 | $1.55M | 15,452 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-01-27 | 2020-01-29 | 4,100 | $117.67 | $482.4K | 28,536 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-01-27 | 2020-01-29 | 190 | $120.21 | $22.8K | 8,595 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-01-27 | 2020-01-29 | 3,365 | $115.55 | $388.8K | 46,267 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-01-27 | 2020-01-29 | 25,000 | $42.22 | $1.06M | 49,632 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-01-27 | 2020-01-29 | 9,374 | $42.22 | $395.8K | 24,632 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-01-27 | 2020-02-12 | 3,663 | $77.40 | $283.5K | 12,258 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-12-23 | 2019-12-26 | 4,583 | — | $0 | 9,166 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-11-22 | 2019-11-26 | 4,583 | — | $0 | 4,583 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-10-10 | 2019-11-26 | 10 | — | $0 | 434 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 6,250 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 3,500 | — | $0 | 14,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-07-11 | 2019-08-07 | 49 | — | $0 | 424 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-06-05 | 2019-06-07 | 6,250 | — | $0 | 18,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-04-09 | 2019-06-07 | 41 | — | $0 | 375 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-02-28 | 2019-03-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-10-18 | 2019-06-07 | 14 | — | $0 | 334 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 6,250 | — | $0 | 12,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 3,500 | — | $0 | 10,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-21 | 2018-08-23 | 3,500 | — | $0 | 7,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2018-08-13 | 2018-08-14 | 605 | $90.95 | $55.0K | 15,258 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2018-08-13 | 2018-08-14 | 1,363 | — | $0 | 15,863 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 1,984 | — | $0 | 5,958 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-07-10 | 2018-08-14 | 32 | — | $0 | 320 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-06-20 | 2018-06-22 | 1,563 | — | $0 | 15,626 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-06-20 | 2018-06-22 | 1,563 | $42.22 | $66.0K | 16,063 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-06-20 | 2018-06-22 | 1,563 | $105.04 | $164.2K | 14,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-04-16 | 2018-06-22 | 31 | — | $0 | 288 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-20 | 2018-03-22 | 1,562 | — | $0 | 17,189 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-20 | 2018-03-22 | 462 | $147.79 | $68.3K | 15,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-20 | 2018-03-22 | 1,562 | $42.22 | $65.9K | 16,062 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-20 | 2018-03-22 | 200 | $151.48 | $30.3K | 14,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-20 | 2018-03-22 | 500 | $149.97 | $75.0K | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-20 | 2018-03-22 | 300 | $152.79 | $45.8K | 14,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-20 | 2018-03-22 | 100 | $146.36 | $14.6K | 15,962 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-13 | 2018-03-14 | 10,000 | — | $0 | 72,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-13 | 2018-03-14 | 10,000 | $77.40 | $774.0K | 24,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-13 | 2018-03-14 | 10,000 | $150.00 | $1.50M | 14,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-12 | 2018-03-14 | 10,000 | — | $0 | 82,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-12 | 2018-03-14 | 10,000 | $140.00 | $1.40M | 14,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-12 | 2018-03-14 | 10,000 | $77.40 | $774.0K | 24,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-03-01 | 2018-03-05 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-12-29 | 2018-01-03 | 3,000 | — | $0 | 92,000 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-12-29 | 2018-01-03 | 3,000 | $77.40 | $232.2K | 14,500 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-12-20 | 2017-12-21 | 6,250 | — | $0 | 6,250 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-12-20 | 2017-12-21 | 6,249 | — | $0 | 18,751 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-12-20 | 2017-12-21 | 4,049 | $120.88 | $489.4K | 13,700 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-12-20 | 2017-12-21 | 6,249 | $42.22 | $263.8K | 17,749 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-12-20 | 2017-12-21 | 1,900 | $121.67 | $231.2K | 11,800 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-12-20 | 2017-12-21 | 300 | $122.53 | $36.8K | 11,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-12-01 | 2017-12-05 | 30,000 | — | $0 | 95,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-12-01 | 2017-12-05 | 6,199 | $137.29 | $851.1K | 11,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-12-01 | 2017-12-05 | 2,800 | $133.37 | $373.4K | 38,700 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-12-01 | 2017-12-05 | 3,801 | $134.59 | $511.6K | 34,899 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-12-01 | 2017-12-05 | 7,500 | $135.56 | $1.02M | 27,399 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-12-01 | 2017-12-05 | 9,700 | $136.50 | $1.32M | 17,699 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-12-01 | 2017-12-05 | 30,000 | $77.40 | $2.32M | 41,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-11-06 | 2017-11-08 | 3,500 | — | $0 | 3,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-07-07 | 2017-07-11 | 1,987 | — | $0 | 3,974 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2017-05-30 | 2017-05-31 | 11,500 | $65.35 | $751.5K | 11,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-12-20 | 2016-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-02-01 | 2016-02-03 | 1,987 | — | $0 | 1,987 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-12-18 | 2015-12-22 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-05-01 | 2015-05-05 | 5,959 | — | $0 | 5,959 | SEC↗ |